Tenders

Medicines with the Active Ingredient Combination Timolol and Latanoprost (Atc: S01ed61)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Medicines with the Active Ingredient Naproxen (Atc Code: M01ae02).

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Pomalidomide (L04ax06) as Part of a So-Called Open House Model.

Medicines with the Active Ingredient Nebivolol (Atc: C07ab12)

Medicines with the Active Ingredient Combination Vilanterol and Umeclidinium Bromide (Atc: R03al03)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Medicines with the Active Ingredient Glycerol Trinitrate (Atc Code: C01da02).

Open House Discount Contracts 2024-07

Drug Contracts with an Option to Join

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion Within the Framework of the So-Called Open House Procedure.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion Within the Framework of the So-Called Open House Procedure.